US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Corgi U.S. Biotech 2x Daily ETF

38.92

-1.3372-3.32%

Volume:912

Turnover:35.49K

Market Cap:778.40K

PE:- -

High:38.92

Open:38.92

Low:38.92

Close:40.26

52wk High:42.22

52wk Low:25.26

Shares:20.00K

Float Shares:20.00K

Volume Ratio:4.77

T/O Rate:4.56%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Healios Secures AMED Funding to Industrialize iPSC-Derived NK Cell Therapy

Chinese biotech overtakes AI as emerging-market growth trade

Srinivasan Sivabalan / Bloomberg

BB Biotech posts strong interim profit and shifts to yield-based dividend policy

NeuroSense Moves PrimeC Toward Health Canada Drug Submission for ALS

Biotech IPO gains crush AI listings with standout 55% return

Anthony Hughes / Bloomberg

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/XBIX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"XBIX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIX\",,,,,undefined,":{"symbol":"XBIX","market":"US","secType":"STK","nameCN":"Corgi U.S. Biotech 2x Daily ETF","latestPrice":38.92,"timestamp":1787587969133,"preClose":40.2572,"halted":0,"volume":912,"delay":0,"changeRate":-0.03321641842949822,"floatShares":20000,"shares":20000,"eps":0,"marketStatus":"Trading","change":-1.3372,"latestTime":"08-24 12:13:54 EDT","open":38.9199,"high":38.92,"low":38.9199,"amount":35494.554816,"amplitude":0.000002,"askPrice":39.47,"askSize":200,"bidPrice":39.34,"bidSize":200,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1787601600000},"marketStatusCode":2,"adr":0,"exchange":"CBOE","adjPreClose":40.2572,"nav":39.14,"aum":782800,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":40.8,"preClose":40.2572,"latestTime":"19:36 EDT","volume":3,"amount":120.1544,"timestamp":1787355411675,"change":0.5428,"changeRate":0.013483,"amplitude":0},"volumeRatio":4.768646},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"XBIX\",,,,,undefined,":{"symbol":"XBIX","floatShares":20000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":4.768646,"shares":20000,"dividePrice":0,"high":38.92,"amplitude":0.000002,"preClose":40.2572,"low":38.9199,"week52Low":25.2639,"pbRate":"--","week52High":42.2188,"institutionHeld":0,"latestPrice":38.92,"eps":0,"divideRate":0,"volume":912,"delay":0,"ttmEps":0,"open":38.9199,"prevYearClose":25.42,"prevWeekClose":40.2572,"prevMonthClose":32.1639,"prevQuarterClose":37.7974,"fiveDayClose":37.5332,"twentyDayClose":33.9733},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/XBIX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"XBIX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"XBIX\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"XBIX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2654509632","title":"Healios Secures AMED Funding to Industrialize iPSC-Derived NK Cell Therapy","url":"https://stock-news.laohu8.com/highlight/detail?id=2654509632","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654509632?lang=en_us&edition=fundamental","pubTime":"2026-07-27 10:52","pubTimestamp":1785120734,"startTime":"0","endTime":"0","summary":"Healios KK ( ($JP:4593) ) has issued an update. Healios K.K., a clinical-stage regenerative medicine biotech in Japan, is developing stem cell-base...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/healios-secures-amed-funding-to-industrialize-ipsc-derived-nk-cell-therapy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/healios-secures-amed-funding-to-industrialize-ipsc-derived-nk-cell-therapy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["AMED","NVIB","XBIX","JP","LU1093756168.USD","BK4135","LU1093756325.SGD","BK4196"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654047803","title":"Chinese biotech overtakes AI as emerging-market growth trade","url":"https://stock-news.laohu8.com/highlight/detail?id=2654047803","media":"Srinivasan Sivabalan / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654047803?lang=en_us&edition=fundamental","pubTime":"2026-07-27 06:33","pubTimestamp":1785105227,"startTime":"0","endTime":"0","summary":"As the artificial-intelligence rally sputters in emerging markets, investors searching for high-growth alternatives are turning to Chinese biotech.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/healthcare/chinese-biotech-overtakes-ai-emerging-market-growth-trade?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/healthcare/chinese-biotech-overtakes-ai-emerging-market-growth-trade?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["KURE","NVIB","AGIX","QQQW","CHAT","AIPO","ARTY","QTOC","VTHR","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653270989","title":"BB Biotech posts strong interim profit and shifts to yield-based dividend policy","url":"https://stock-news.laohu8.com/highlight/detail?id=2653270989","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653270989?lang=en_us&edition=fundamental","pubTime":"2026-07-24 13:34","pubTimestamp":1784871252,"startTime":"0","endTime":"0","summary":"The latest announcement is out from BB Biotech ( ($CH:BION) ). BB Biotech AG, a specialist biotech investment company listed in Switzerland and Ger...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/bb-biotech-posts-strong-interim-profit-and-shifts-to-yield-based-dividend-policy?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/bb-biotech-posts-strong-interim-profit-and-shifts-to-yield-based-dividend-policy?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["XBIX","US7Y.BOND","BK4585","NVIB","BK4581","TLTW","US10Y.BOND","US2Y.BOND","BK4588","BK4097","XBI","VIG","US5Y.BOND","TLT","US12M.BOND","US30Y.BOND","TMF","US3Y.BOND","US6M.BOND","BK4547","LEAD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653768188","title":"NeuroSense Moves PrimeC Toward Health Canada Drug Submission for ALS","url":"https://stock-news.laohu8.com/highlight/detail?id=2653768188","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653768188?lang=en_us&edition=fundamental","pubTime":"2026-07-22 20:56","pubTimestamp":1784725011,"startTime":"0","endTime":"0","summary":"Neurosense Therapeutics Ltd. ( ($NRSN) ) just unveiled an update. NeuroSense Therapeutics, a late-stage clinical biotech developer of neurodegenera...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/neurosense-moves-primec-toward-health-canada-drug-submission-for-als?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/neurosense-moves-primec-toward-health-canada-drug-submission-for-als?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["NVIB","XBIX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653784051","title":"Biotech IPO gains crush AI listings with standout 55% return","url":"https://stock-news.laohu8.com/highlight/detail?id=2653784051","media":"Anthony Hughes / Bloomberg","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653784051?lang=en_us&edition=fundamental","pubTime":"2026-07-21 12:57","pubTimestamp":1784609865,"startTime":"0","endTime":"0","summary":"The biotechnology sector is stealing the US IPO market thunder from artificial intelligence-related listings, delivering standout returns as bankers line up a steady stream of summer debuts.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"edge_highlight","url":"https://www.theedgesingapore.com/news/us-stocks/biotech-ipo-gains-crush-ai-listings-standout-55-return?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.theedgesingapore.com/news/us-stocks/biotech-ipo-gains-crush-ai-listings-standout-55-return?utm_source=Blog&utm_medium=RSS&utm_campaign=Tiger_Brokers_app_RSS","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"edge_highlight","symbols":["PEVC","LRCY","REDS","FRHC","QQQJ","BK4581","TMFX","XBI","BKIV","BK4588","VTHR","ARTY","NVIB","KCE","AIPO","KI","AGIX","IJT","QTOC","BK4127","CHAT","BK4585","IPO","IPOS","XBIX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":2,"totalSize":25,"code":"91000000","status":"200"}]}}